Study links weight-loss injections to lower cancer risk

Study finds GLP-1 drugs may reduce risk of more than a dozen cancers, offering hope in Louisiana where obesity-related cancer ...

Penn, CHOP will test gene therapy for rare diseases with new FDA trial protocol

Penn and CHOP researchers want to develop urea cycle disorder treatments using CRISPR gene-editing therapy. Get unlimited access to Inquirer.com and The Inquirer App, plus 5 articles each month to ...

Lifelong drugs for autoimmune diseases don’t work well. Now scientists are trying something new

There's a new frontier in treating autoimmune diseases. Today's treatments tamp down the friendly fire but don't fix what's ...
BioPharma Dive

Korro to cut staff, shift strategy as RNA editing drug misses mark in early testing

Korro’s lead program for alpha-1 antitrypsin deficiency wasn’t as potent as anticipated, leading the company to change course ...
Petit Chef on MSN

What researchers have discovered about sugary sodas changes everything we thought we knew about the microbiota

Did you think that the sugar in soft drinks "only" gave you cavities or a few extra pounds? According to a study relayed by ...

Bionano Genomics, Inc. (BNGO) Q3 2025 Earnings Call Transcript

Bionano Genomics, Inc. ( BNGO) Q3 2025 Earnings Call November 13, 2025 4:30 PM EST Good day, and welcome to the Bionano Third Quarter 2025 Earnings Conference Call. Today's conference is being ...
Lifestyle.INQ on MSN

Celine Lee stitches the human in a world of code

Through thread and cloth, visual artist Celine Lee probes the boundaries between art, technology, and human agency ...
Labiotech.eu

iGEM Jamboree: leap into the synthetic biology future

From plastic-eating plants to AI-guided therapies, iGEM 2025 reveals the innovations defining the future of synthetic biology ...